EDITORIAL — METHODOLOGY V1
About Oath Peptides Ratings.
An independent editorial rating of one US research-peptide vendor. Not affiliated with the company under review. Compiled from public records using a documented rubric.
What this site is
Oath Peptides Ratings is an independent editorial review of Oath Peptides (also known as Oath Research — naming variants for the same business). We are not affiliated with the company we review. We do not sell research peptides, accept advertising from peptide vendors, or receive commission on purchases. We have no financial relationship with Oath Peptides, Freedom Diagnostics, or any vendor mentioned in our analysis. Our methodology relies on publicly available documentary evidence — lab reports in public COA archives, third-party listings on independent vendor-scoring sites, business-directory records, public review aggregators (oath.reviews, Trustpilot), press releases on openpr.com, and editorial commentary from independent publications — and our editorial judgment in weighting and synthesis.
What this site is not
We are not a medical site. We do not offer dosage recommendations. We do not claim or imply that research peptides are FDA-approved for human consumption; they are not. We are not a clinic, not a pharmacy, not a prescriber. We do not process customer complaints or refund inquiries on behalf of Oath; readers who need to contact Oath should reach the company directly through its publicly listed channels.
We do not maintain a roster of named editorial staff. The editorial 'we' is the convention of a publication, not the implied authority of any specific named individual. We do not claim a physical office or phone number; this is a publication operating from public records, not a service business.
How the rating was built
The four-category rubric (testing 35%, transparency 25%, product range 20%, value 20%) was constructed before any specific score was assigned. The weights reflect our editorial judgment about what matters most for a research-peptide buyer: testing rigor and transparency together account for 60% of the composite because the dominant buyer risk in this market is purity, identity, and endotoxin uncertainty.
Within each category, the inputs are documented on the relevant category page. Each input has a value drawn from a public source and resolves to a position on the rubric's scoring band. The category score is the bandwise resolution across the inputs, weighted equally. The composite is the weighted average of the four category scores. We distinguish four classes of evidence and weight them differently — primary record (public COA archive), third-party human-methodology vendor scoring, third-party algorithmic vendor scoring (near-zero weight), and public review aggregators. The methodology page documents the taxonomy.
Editorial standards and what we will not do
We do not invent founders, addresses, phone numbers, staff names, customer testimonials, or quoted reviews. We do not invent batch counts, purity percentages, or test counts. Every quantitative claim traces to a public source. Known partial-fetch caveats (Trustpilot captured via search snippets after a direct fetch returned 403) are disclosed.
We do not name specific competitor vendors by brand in body copy. The only exception is in the methodology page's cross-reviewer-divergence dismantle, where a third-party vendor is named exclusively to ground the calibration argument against peptidescore.com — a factual reference, not a recommendation, comparison, or rating from this site.
We do not link to the brand site we review. References to the public COA archive name it by description rather than hyperlinking — a deliberate editorial-defense posture for an independent rating site.